Stockscreener 앱 받기
74.30
1.38%
-1.04
시장 영업 전:
74.31
0.01
+0.01%
전일 마감가:
$75.34
열려 있는:
$74.17
하루 거래량:
4.46M
Relative Volume:
1.24
시가총액:
$29.14B
수익:
$4.30B
순이익/손실:
$571.50M
주가수익비율:
51.60
EPS:
1.44
순현금흐름:
$570.80M
1주 성능:
-2.39%
1개월 성능:
-6.28%
6개월 성능:
-15.92%
1년 성능:
+7.15%
1일 변동 폭
$73.47
$75.11
1주일 범위
$73.47
$76.97
52주 변동 폭
$57.52
$93.25
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
DXCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
74.30 | 29.54B | 4.30B | 571.50M | 570.80M | 1.44 |
|
ABT
Abbott Laboratories
|
131.46 | 230.89B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.66 | 156.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
389.94 | 149.64B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.33 | 119.05B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.77 | 47.75B | 5.69B | 1.41B | 577.90M | 6.95 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
Analyzing DexCom Inc. with risk reward ratio chartsMarket Risk Analysis & Trade Opportunity Analysis Reports - Newser
Understanding DexCom Inc.’s price movementJuly 2025 Breakouts & Expert-Curated Trade Recommendations - Newser
What candlestick patterns are forming on DexCom Inc.2025 Institutional Moves & Weekly Breakout Watchlists - Newser
Exit strategy if you’re trapped in DexCom Inc.July 2025 Analyst Calls & Daily Stock Trend Watchlist - Newser
Using data filters to optimize entry into DexCom Inc.July 2025 Institutional & Consistent Profit Alerts - Newser
Custom watchlist performance reports with DexCom IncMarket Performance Report & Fast Moving Stock Watchlists - Newser
DexCom Faces Evaluation Adjustment Amid Strong Financial Performance and Quality Concerns - Markets Mojo
Stock Analysis | Dexcom OutlookWeak Technicals and Mixed Analyst Sentiment - AInvest
Should you hold or exit DexCom Inc. nowTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - Newser
Dexcom Trails Medtronic in Diabetes Tech Race as $330M Volume Marks 343rd Market Rank - AInvest
What to do if you’re stuck in DexCom Inc.Trade Risk Summary & Free High Return Stock Watch Alerts - Newser
DexCom Loses EU Patent For Glucose Sensor Design - Law360
Tools to assess DexCom Inc.’s risk profileQuarterly Risk Review & Low Drawdown Trading Strategies - Newser
Applying Wyckoff theory to DexCom Inc. stockJuly 2025 Pullbacks & Weekly Market Pulse Updates - Newser
Using RSI to spot recovery in DexCom Inc.Index Update & Proven Capital Preservation Methods - Newser
Is DexCom Inc. trending in predictive chart modelsJuly 2025 Spike Watch & Weekly Setup with High ROI Potential - Newser
Market reaction to DexCom Inc.’s recent newsGap Down & Free Long-Term Investment Growth Plans - Newser
Will DexCom Inc. benefit from government policy2025 Market Overview & Community Trade Idea Sharing - خودرو بانک
How to recover losses in DexCom Inc. stockJuly 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - Newser
What data driven models say about DexCom Inc.’s futureJuly 2025 Earnings & Fast Entry and Exit Trade Plans - Newser
How to use a screener to detect DexCom Inc. breakoutsJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - Newser
Analyzing drawdowns of DexCom Inc. with statistical toolsWeekly Investment Recap & Smart Money Movement Tracker - Newser
Custom watchlist performance reports with DexCom Inc.Trend Reversal & Precise Buy Zone Identification - Newser
What is DexCom Inc.’s TAM (Total Addressable Market)Dollar Strength & High Accuracy Trade Alerts - خودرو بانک
Can DexCom Inc. benefit from deglobalization2025 Stock Rankings & Fast Entry High Yield Stock Tips - خودرو بانک
Using R and stats models for DexCom Inc. forecastingWeekly Earnings Recap & Proven Capital Preservation Tips - Newser
Can trapped investors hope for a rebound in DexCom Inc.Weekly Risk Report & AI Powered Market Entry Strategies - Newser
Will DexCom Inc. continue its uptrendJuly 2025 Macro Moves & High Return Trade Opportunity Guides - Newser
What momentum shifts mean for DexCom Inc.Weekly Market Outlook & Low Volatility Stock Recommendations - Newser
Short interest data insights for DexCom Inc.July 2025 PreEarnings & Verified Swing Trading Watchlists - Newser
Ranking DexCom Inc. among high performing stocks via toolsQuarterly Profit Review & Safe Investment Capital Preservation Plans - Newser
Marvell Technology, eBay, And DexCom Are Among Top 10 Large Cap Losers Last Week (August 25-August 29): Are The Others In Your Portfolio? - Benzinga
DexCom P/E Ratio Analysis: Undervalued or Overvalued? - AInvest
Risk adjusted return profile for DexCom Inc. analyzed2025 Geopolitical Influence & Consistent Growth Equity Picks - Newser
Argus Initiates Coverage of DexCom (DXCM) with a Buy Rating - Yahoo Finance
What makes DexCom Inc. stock price move sharply getLinesFromResByArray error: size == 0 - thegnnews.com
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.89%
1.48%
자본화:
|
볼륨(24시간):